Safeguarding American Genetic Data Act of 2023

S 3411, the Safeguarding American Genetic Data Act of 2023, prohibits U.S. federal agencies from directly procuring biotechnology equipment or services from companies designated as posing national security risks due to ties with foreign adversaries (like BGI or MGI). It requires the Office of Management and Budget to establish a list of such "biotechnology companies of concern" within 180 days and issue guidance banning federal procurement from them, with limited exceptions for overseas military health services and publicly available data. Agencies must find alternative providers, report on existing contracts with covered companies, and develop strategies to mitigate security risks while ensuring continued access to necessary services. The bill mandates annual reviews of the company list and detailed congressional reporting on implementation and alternatives.